Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05990712Phase 4Unknown
Phase 4, randomised, open-label trial (2 arms), sponsored by Uptown Eye Specialists. Primary endpoints: Matrix Metallopeptidase 9, Conjunctival Microbial Load and 1 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05990712.